BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

551 related articles for article (PubMed ID: 31940661)

  • 21. Elevated serum levels of kynurenine pathway metabolites in patients with Behçet disease.
    Eryavuz Onmaz D; Tezcan D; Abusoglu S; Sivrikaya A; Kuzu M; Yerlikaya FH; Yilmaz S; Unlu A
    Amino Acids; 2022 Jun; 54(6):877-887. PubMed ID: 35604497
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of the immune-kynurenine pathway in treatment-resistant schizophrenia.
    Chen W; Tian Y; Gou M; Wang L; Tong J; Zhou Y; Feng W; Li Y; Chen S; Liu Y; Wang Z; Pan S; Zhang P; Huang J; Yang X; Li CR; Tian L; Hong LE; Tan Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2024 Mar; 130():110926. PubMed ID: 38147973
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peripheral and cerebral metabolic abnormalities of the tryptophan-kynurenine pathway in a murine model of major depression.
    Laugeray A; Launay JM; Callebert J; Surget A; Belzung C; Barone PR
    Behav Brain Res; 2010 Jun; 210(1):84-91. PubMed ID: 20153778
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peripheral and central kynurenine pathway abnormalities in major depression.
    Paul ER; Schwieler L; Erhardt S; Boda S; Trepci A; Kämpe R; Asratian A; Holm L; Yngve A; Dantzer R; Heilig M; Hamilton JP; Samuelsson M
    Brain Behav Immun; 2022 Mar; 101():136-145. PubMed ID: 34999196
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A mechanism of quinolinic acid formation by brain in inflammatory neurological disease. Attenuation of synthesis from L-tryptophan by 6-chlorotryptophan and 4-chloro-3-hydroxyanthranilate.
    Heyes MP; Saito K; Major EO; Milstien S; Markey SP; Vickers JH
    Brain; 1993 Dec; 116 ( Pt 6)():1425-50. PubMed ID: 8293279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dysregulation of kynurenine metabolism is related to proinflammatory cytokines, attention, and prefrontal cortex volume in schizophrenia.
    Kindler J; Lim CK; Weickert CS; Boerrigter D; Galletly C; Liu D; Jacobs KR; Balzan R; Bruggemann J; O'Donnell M; Lenroot R; Guillemin GJ; Weickert TW
    Mol Psychiatry; 2020 Nov; 25(11):2860-2872. PubMed ID: 30940904
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tryptophan metabolite concentrations in depressed patients before and after electroconvulsive therapy.
    Ryan KM; Allers KA; McLoughlin DM; Harkin A
    Brain Behav Immun; 2020 Jan; 83():153-162. PubMed ID: 31606477
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tryptophan Metabolism and Neurodegeneration: Longitudinal Associations of Kynurenine Pathway Metabolites with Cognitive Performance and Plasma Alzheimer's Disease and Related Dementias Biomarkers in the Duke Physical Performance Across the LifeSpan Study.
    Parker DC; Kraus WE; Whitson HE; Kraus VB; Smith PJ; Cohen HJ; Pieper CF; Faldowski RA; Hall KS; Huebner JL; Ilkayeva OR; Bain JR; Newby LK; Huffman KM
    J Alzheimers Dis; 2023; 91(3):1141-1150. PubMed ID: 36565121
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Altered kynurenine pathway metabolism and association with disease activity in patients with systemic lupus.
    Eryavuz Onmaz D; Tezcan D; Yilmaz S; Onmaz M; Unlu A
    Amino Acids; 2023 Dec; 55(12):1937-1947. PubMed ID: 37925676
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psychological outcomes of COVID-19 survivors at sixth months after diagnose: the role of kynurenine pathway metabolites in depression, anxiety, and stress.
    Kucukkarapinar M; Yay-Pence A; Yildiz Y; Buyukkoruk M; Yaz-Aydin G; Deveci-Bulut TS; Gulbahar O; Senol E; Candansayar S
    J Neural Transm (Vienna); 2022 Aug; 129(8):1077-1089. PubMed ID: 35796878
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The kynurenine pathway in chronic diseases: a compensatory mechanism or a driving force?
    Joisten N; Ruas JL; Braidy N; Guillemin GJ; Zimmer P
    Trends Mol Med; 2021 Oct; 27(10):946-954. PubMed ID: 34373202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cross-sectional relationship between kynurenine pathway metabolites and cognitive function in major depressive disorder.
    Zhou Y; Zheng W; Liu W; Wang C; Zhan Y; Li H; Chen L; Ning Y
    Psychoneuroendocrinology; 2019 Mar; 101():72-79. PubMed ID: 30419374
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kynurenine pathway changes in late-life depression with memory deficit.
    Wu Y; Mai N; Zhong X; Wen Y; Zhou Y; Li H; Shang D; Hu L; Chen X; Chen B; Zhang M; Ning Y
    Psychiatry Res; 2018 Nov; 269():45-49. PubMed ID: 30145300
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dynamic changes in metabolites of the kynurenine pathway in Alzheimer's disease, Parkinson's disease, and Huntington's disease: A systematic Review and meta-analysis.
    Fathi M; Vakili K; Yaghoobpoor S; Tavasol A; Jazi K; Hajibeygi R; Shool S; Sodeifian F; Klegeris A; McElhinney A; Tavirani MR; Sayehmiri F
    Front Immunol; 2022; 13():997240. PubMed ID: 36263032
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The kynurenine pathway is involved in bacterial meningitis.
    Coutinho LG; Christen S; Bellac CL; Fontes FL; Souza FR; Grandgirard D; Leib SL; Agnez-Lima LF
    J Neuroinflammation; 2014 Oct; 11():169. PubMed ID: 25274277
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The possible role of the kynurenine pathway in adolescent depression with melancholic features.
    Gabbay V; Klein RG; Katz Y; Mendoza S; Guttman LE; Alonso CM; Babb JS; Hirsch GS; Liebes L
    J Child Psychol Psychiatry; 2010 Aug; 51(8):935-43. PubMed ID: 20406333
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Capillary electrochromatography-mass spectrometry of kynurenine pathway metabolites.
    Chawdhury ASMMR; Shamsi SA; Miller A; Liu A
    J Chromatogr A; 2021 Aug; 1651():462294. PubMed ID: 34098249
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Different Kynurenine Pathway Dysregulation in Systemic Sclerosis in Men and Women.
    Turska-Kozłowska M; Pedraz-Petrozzi B; Paluszkiewicz P; Parada-Turska J
    Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612652
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The tryptophan catabolite or kynurenine pathway in schizophrenia: meta-analysis reveals dissociations between central, serum, and plasma compartments.
    Almulla AF; Vasupanrajit A; Tunvirachaisakul C; Al-Hakeim HK; Solmi M; Verkerk R; Maes M
    Mol Psychiatry; 2022 Sep; 27(9):3679-3691. PubMed ID: 35422466
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differentiation of viral and autoimmune central nervous system inflammation by kynurenine pathway.
    Luo Y; Möhn N; Skripuletz T; Senel M; Tumani H; Peßler F; Sühs KW; Stangel M
    Ann Clin Transl Neurol; 2021 Dec; 8(12):2228-2234. PubMed ID: 34623755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.